Korean Circ J.  2024 Sep;54(9):545-548. 10.4070/kcj.2024.0195.

Exploring New Combination Strategy of Lipid-Lowering Therapies for Primary Prevention of Cardiovascular Disease

• Cho JH
• Cho EJ
• Jeong YH

• KMID: 2559126
• DOI: http://doi.org/10.4070/kcj.2024.0195

Reference

1. Hwang IC, Kim CH, Kim JY, et al. Changes in risk factor status and risk of future ASCVD events in primary prevention. Korean Circ J. 2024; 54:354–356. PMID: 38767443.

2. Sever PS, Dahlöf B, Poulter NR, et al. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet. 2003; 361:1149–1158. PMID: 12686036.

3. Nakamura H, Arakawa K, Itakura H, et al. Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial. Lancet. 2006; 368:1155–1163. PMID: 17011942.

4. Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008; 359:2195–2207. PMID: 18997196.

5. Yusuf S, Bosch J, Dagenais G, et al. Cholesterol lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016; 374:2021–2031. PMID: 27040132.

6. Chou R, Cantor A, Dana T, et al. Statin use for the primary prevention of cardiovascular disease in adults: updated evidence report and systematic review for the US Preventive Services Task Force. JAMA. 2022; 328:754–771. PMID: 35997724.

7. Ouchi Y, Sasaki J, Arai H, et al. Ezetimibe Lipid-Lowering Trial on Prevention of Atherosclerotic Cardiovascular Disease in 75 or older (EWTOPIA 75): a randomized, controlled trial. Circulation. 2019; 140:992–1003. PMID: 31434507.

8. Nissen SE, Menon V, Nicholls SJ, et al. Bempedoic acid for primary prevention of cardiovascular events in statin-intolerant patients. JAMA. 2023; 330:131–140. PMID: 37354546.

9. Baigent C, Landray MJ, Reith C, et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011; 377:2181–2192. PMID: 21663949.

10. Cha JJ, Hong SJ, Lim S, et al. Comparison of statin with ezetimibe combination therapy versus statin monotherapy for primary prevention in middle-aged adults. Korean Circ J. 2024; 54:534–544. PMID: 38956936.

11. Jun JE, Jeong IK, Ahn KJ, Chung HY, Hwang YC. Combination of low- or moderate-intensity statin and ezetimibe versus high-intensity statin monotherapy on primary prevention of cardiovascular disease and all-cause death: a propensity-matched nationwide cohort study. Eur J Prev Cardiol. 2024; [Epub ahead of print].

12. Yoon M, Lee CJ, Park S, Lee SH. Statins and clinical outcomes in patients with low to moderate risk but with non-obstructive carotid plaques: the SCOPE-CP study. Korean Circ J. 2022; 52:890–900. PMID: 36478652.